Radovanovic Stojanovic & Partners has advised the shareholders of Belgrade-based pharmacy chain Emily Pharm on the sale of all their shares to the Dr. Max Group.
B2RLaw Advises IQ Biozoom on Receiving VC Link Investment
B2RLaw has advised biochemical monitoring start-up IQ Biozoom on its investment round led by the VC Link fund.
Cobalt Successful for Interchemie on Court Agreement with Kepro
Cobalt has advised Interchemie on the court dispute and resulting agreement with competitor Kepro regarding the termination of Interchemie's lease agreement and eviction from their factory.
Gessel Advises Bioceltix Shareholders on Public Offering
Gessel has advised the shareholders of Bioceltix on their recent over PLN 20 million no-prospectus public offering of company shares carried out under an accelerated book-building procedure.
Inside Insight: Interview with Lucie Kubenova of Pfizer
Pfizer Eastern Europe Cluster Legal Lead and Legal Director Lucie Kubenova talks about her career leading to her current role and managing her team at Pfizer.
NKO Advises Dr. Max on Acquisition of Uniprom Pharmacy Chain
NKO has advised the Dr. Max Group on its acquisition of the Uniprom pharmacy chain in Zajecar.
Healthcare in Serbia: From Public to Private
The Serbian private healthcare sector – including private healthcare providers and pharmacies – has been on a steady incline over the past several years. BDK Advokati Senior Partner Vladimir Dasic, Prica & Partners Partner Tijana Lalic, and Karanovic & Partners Senior Partner Marjan Poljak take a deep dive into what makes the sector tick and grow.